National Research Corporation (NRC), dba NRC Health, announced that its Board of Directors authorized a stock repurchase program of up to $60M of the company’s outstanding common stock through March 31, 2028.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRC: